Fidelity® Select Pharmaceuticals Portfolio

Class No Load (FPHAX)
Scorecard
4 / 5 Stars
Lipper
4 4 5 5 2
Zacks Investment Research
1 (Strong Buy)
Standard & Poor's
3 / 5 Stars
TheStreet.com
A+ (Buy)

Fund Fees

Updated 04.29.2013

Maximum Sales Fees %
Initial
Deferred

Updated 04.29.2013

Maximum Fees %
Administrative
Management 0.3
Redemption 0.75

Updated 04.29.2013

Actual Fees %
12b-1
Management 0.56
Net Expense Ratio: Annual Report 0.84
Net Expense Ratio: Prospectus 0.85

Updated 03.05.2014

Total Cost Projections
3-Year $271.00
5-Year $471.00
10-Year $1,049.00

Purchase Information

Updated 04.29.2013

Minimum Investments
Initial $2,500.00
Additional
Initial IRA $200.00
Additional IRA $200.00
Initial AIP $2,500.00
Additional AIP